March 3rd, 2014
New Guidelines Issued for Valvular Heart Disease
Larry Husten, PHD
The American Heart Association and the American College of Cardiology today released new practice guidelines for the management of patients with valvular heart disease (VHD). Among its most notable features, the new document provides a new system of classification for VHD and lowers the threshold for interventions, including, for the first time, transcatheter as well […]
March 3rd, 2014
Pfizer Starts Testing for Over-the-Counter Atorvastatin
Larry Husten, PHD
Looking backward to improve its future, Pfizer will once again try to gain FDA approval to market its blockbuster drug, atorvastatin (Lipitor), over-the-counter (OTC). Peter Loftus reports in the Wall Street Journal that the company has started a clinical study to support the application for low-dose atorvastatin (10 mg). Over-the-counter statins have been unsuccessfully proposed in the past. […]